The study was approved by the Bioethics Committee of the Military Institute of Medicine in Warsaw and adhered to the tenets of the Declaration of Helsinki. A written consent was obtained from all participants after they had been informed about the study character of the intervention and the surgical alternatives, and after declaring their participation in the study for at least 12 months.
Primary open-angle glaucoma and pseudoexfoliation glaucoma (PEX) with a possible coexisting cataract was an indication for surgery. Additional inclusion criteria encompassed unsatisfying IOP control despite maximally tolerated medication, well-documented progression of the visual field, noncompliance in antiglaucoma therapy, and allergy to topical medication. Exclusion criteria included unwillingness to participate, dry eye syndrome, intolerance to contact lens wear, any previous surgical procedure within the eye, poorly controlled diabetes mellitus with diabetic retinopathy, advanced macular degeneration, active inflammatory disease, atrial fibrillation, and patients with cardiac pacemakers.